Closing Bell: Arch Biopartners Inc down on Monday (ARCH)

In market activity today, shares of Arch Biopartners Inc opened at $1.58 and closed at $1.56. prices ranged from a low of $1.53 to a high of $1.59.

Share prices dipped -1.89 percent from the previous day's close of $1.59.

Today across North America, the TSX Composite closed -0.15% at 22779.57, the S&P 500 closed 1.11% at 5459.10, the Dow Jones Industrial Average closed 1.64% at 40589.34 and the Nasdaq Composite closed 1.03% at 17357.88.

Arch Biopartners Inc has listed on the Toronto Venture Exchange (TSX-V) under the ticker ARCH.

A total of 9,484 shares was traded during the session, with total trades of 34, while having an average volume of 24,180 over 5 days.

Trading across the entire TSX-V saw 1,903 price advancers against 3,356 declines and 91 unchanged.

During the prior 52 weeks, ARCH.VN has traded as high as $2.56 (March 18,2024) and low as $0.97 (November 03,2023). Moreover, the shares have lost -25.71 percent in 52 weeks, while they have boosted 5.41% year-to-date.

It announced a 0.05 dividend on January 01/70, with an December 05/89 ex-date and January 01/70 pay day.

Following today's trading, Arch Biopartners Inc has a market capitalization of $101.52 million on a float of 63,851 shares outstanding. Its annual EPS is $-0.03.

Arch Biopartners Inc is a TSX Biotechnology company headquartered in Toronto, CAN.

Currently, Arch Biopartners Inc has an average recommendation of "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..